Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic

Completed · Not applicable · Has a placebo group

Conditions studied: Schizophrenia, Cognition, Cigarette Smoking

In brief

This is a study of the effects of tDCS on smoking, craving for cigarettes, cognition, and psychiatric symptoms in schizophrenic patients who are current smokers or have a history of regular cigarette smoking. It assesses smoking with CO monitoring, nicotine and nicotine levels, and craving with QSU scale and response to craving slides. Cognition is measured by MCCB, symptoms are measured by PANSS and hallucination scale. This is a double-blind sham-controlled study with active tDCS 2ma or 20 minutes over 5 days, and sham tDCS for 40 seconds on each sham occasion.

Key facts

Study ID

NCT02128919

Run by

Nathan Kline Institute for Psychiatric Research

People needed

33

Starts

2012-04-01

Expected to finish

2016-12-01

Last updated by the study team

2017-08-30

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of schizophrenia spectrum disorder History of cigarette smoking

You may not qualify if…

• Seizure disorder or current treated neurological illness Current Acute exacerbation of psychotic state

Where it is running

• Nathan Kline Institute for Psychiatric Research — Orangeburg, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.